Ftse Mib
32.885,39
-0,85%
DAX
19.170,93
-0,69%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
93.390,14
1,54%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Celularity Inc (CELU) Celularity Inc (CELU) Notizie

CELU

Celularity (CELU)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CELU
DataOraFonteTitoloSimboloCompagnia
20/11/202414:30GlobeNewswire Inc.Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia PacificNASDAQ:CELUCelularity Inc
18/11/202414:30GlobeNewswire Inc.Celularity Inc. Announces Resolution of Nasdaq Listing Compliance MatterNASDAQ:CELUCelularity Inc
07/11/202414:00GlobeNewswire Inc.Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 MillionNASDAQ:CELUCelularity Inc
23/10/202414:30GlobeNewswire Inc.Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings PanelNASDAQ:CELUCelularity Inc
22/10/202414:30GlobeNewswire Inc.Celularity Provides Corporate UpdateNASDAQ:CELUCelularity Inc
19/10/202400:00GlobeNewswire Inc.Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an AppealNASDAQ:CELUCelularity Inc
16/10/202423:15GlobeNewswire Inc.Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.NASDAQ:CELUCelularity Inc
05/09/202422:05GlobeNewswire Inc.Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment ConferenceNASDAQ:CELUCelularity Inc
28/08/202423:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELUCelularity Inc
28/08/202422:45GlobeNewswire Inc.Celularity Appoints Richard J. Berman to its Board of DirectorsNASDAQ:CELUCelularity Inc
23/08/202423:00GlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q FilingNASDAQ:CELUCelularity Inc
16/08/202422:45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CELUCelularity Inc
31/07/202414:30GlobeNewswire Inc.Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023NASDAQ:CELUCelularity Inc
30/07/202422:26Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CELUCelularity Inc
03/06/202414:38GlobeNewswire Inc.Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CELUCelularity Inc
14/05/202415:15GlobeNewswire Inc.Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T TherapyNASDAQ:CELUCelularity Inc
22/04/202414:00GlobeNewswire Inc.Celularity Inc. to Host Investor and Analyst Research & Development DayNASDAQ:CELUCelularity Inc
19/04/202423:30GlobeNewswire Inc.Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingNASDAQ:CELUCelularity Inc
18/04/202422:30GlobeNewswire Inc.Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024NASDAQ:CELUCelularity Inc
15/04/202414:00GlobeNewswire Inc.Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial ProductsNASDAQ:CELUCelularity Inc
08/04/202415:00GlobeNewswire Inc.Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental CellsNASDAQ:CELUCelularity Inc
26/03/202414:00GlobeNewswire Inc.Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3LNASDAQ:CELUCelularity Inc
20/03/202414:15GlobeNewswire Inc.Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular DystrophyNASDAQ:CELUCelularity Inc
14/03/202414:15GlobeNewswire Inc.Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE SummitNASDAQ:CELUCelularity Inc
12/03/202414:20GlobeNewswire Inc.Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World CongressNASDAQ:CELUCelularity Inc
07/03/202415:35GlobeNewswire Inc.Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental CellsNASDAQ:CELUCelularity Inc
23/02/202422:10GlobeNewswire Inc.Celularity Announces 1-for-10 Reverse Stock SplitNASDAQ:CELUCelularity Inc
22/02/202403:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELUCelularity Inc
14/02/202422:05GlobeNewswire Inc.Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface DiseaseNASDAQ:CELUCelularity Inc
02/02/202412:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CELUCelularity Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CELU

La tua Cronologia

BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
ISP
Intesa Sanpaolo
BIT
BAMI
Banco BPM
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
G
Generali
BIT
RACE
Ferrari NV
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
TEN
Tenaris
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network